Exploring the interaction between human focal adhesion kinase and inhibitors: a molecular dynamic simulation and free

Jiu-Yu Zhan1, Ji-Long Zhang1, Yan Wang1

  • 1a State Key Laboratory of Theoretical and Computational Chemistry, Institute of Theoretical Chemistry , Jilin University , Changchun 130023 , P.R. China.

Insights

Focal adhesion kinase (FAK) inhibitors show promise as anticancer agents. Molecular dynamics simulations reveal key interactions between FAK and inhibitors, guiding future drug design for cancer treatment.

Area of Science:

  • Biochemistry
  • Computational Chemistry
  • Oncology

Background:

  • Focal adhesion kinase (FAK) is a significant therapeutic target for various cancers.
  • Developing novel FAK inhibitors is crucial for effective anticancer therapies.
  • Understanding FAK-inhibitor interactions is key to designing potent drugs.

Purpose of the Study:

  • To investigate the interaction characteristics between FAK and three inhibitors (PHM16, TAE226, ligand3).
  • To utilize Molecular Dynamics (MD) simulations and MM-GB/SA calculations for this exploration.
  • To identify key residues involved in FAK-inhibitor binding for future drug design.

Main Methods:

  • Employed Molecular Dynamics (MD) simulation techniques.
  • Utilized MM-GB/SA calculations to analyze binding thermodynamics.
  • Analyzed electronic static potential to understand charge distribution.

Main Results:

  • FAK-inhibitor interactions are primarily enthalpy-driven.
  • Cys502 and Asp564 are critical for hydrogen bonding with inhibitors.
  • Hydrophobic interactions involve residues Ile428, Val436, Ala452, Val484, Leu501, Glu505, Glu506, Leu553, Gly563, Leu567, and Ser568.

Conclusions:

  • Identified essential residues (Cys502, Asp564, Glu500, Arg426) and hydrophobic residues crucial for FAK inhibitor binding.
  • Findings align with experimental data, validating the simulation approach.
  • The identified key residues will aid in the rational design of new FAK inhibitors for cancer therapy.